Beclin 1 Phosphorylation Screening for Autophagy Regulators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective mechanism for screening autophagy activators or inhibitors that regulate cellular homeostasis, with unclear mechanisms and functions of involved molecules in autophagy processes.
Innovation Solution
A method involving the analysis of the phosphorylation degree of the 30th amino acid residue serine of Beclin 1 protein to determine if a test material acts as an autophagy activator or inhibitor, using specific antibodies to assess phosphorylation levels in cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional screening methods are used for autophagy activators or inhibitors, then the screening process can be performed with existing techniques, but the mechanisms and functions of involved molecules remain unclear and screening effectiveness is limited
Solution Approach 1:
The patent uses fluorescent markers that change emission color or intensity based on autophagy activity levels. Specifically, fluorescent proteins are designed to exhibit different fluorescence signals when autophagy is activated versus inhibited, enabling visual detection and quantification of autophagy regulator activity without requiring complex mechanistic analysis
Solution Approach 2:
The patent introduces fluorescent marker molecules as intermediaries that bind to or report on the activity state of autophagy-related molecules. These markers serve as mediators between the complex intracellular autophagy machinery and the detectable signal, allowing researchers to screen regulators effectively while the fluorescent markers themselves provide information about molecular interactions
2Loss of information
If detailed mechanistic analysis is performed to understand autophagy molecule functions, then mechanism clarity is improved, but the screening process becomes more complex and time-consuming
Solution Approach 1:
The patent extracts the essential functional information about autophagy activity from complex cellular processes by using fluorescent markers that report only the relevant activity state. This extraction approach isolates the key signal (autophagy activation/inhibition) from the complexity of underlying molecular mechanisms, providing clarity without requiring full mechanistic dissection
Solution Approach 2:
The patent monitors changes in fluorescent signal parameters (intensity, wavelength, localization) that directly correlate with autophagy activity states. By focusing on these measurable parameter changes rather than comprehensive mechanistic analysis, the method achieves mechanism clarity through quantitative signal variation while maintaining screening simplicity
3Adaptability or versatility
If comprehensive autophagy regulation screening is performed to identify both activators and inhibitors, then the versatility of the screening method is improved, but the difficulty of detecting and measuring autophagy activity increases
Solution Approach 1:
The patent employs fluorescent markers with inverted or contrasting signal responses for different autophagy states. Activators and inhibitors produce distinguishable fluorescent patterns or intensity changes, allowing both types of regulators to be detected using the same screening platform. The inverted signaling approach enables simultaneous identification of opposing regulatory activities without requiring separate detection methodologies
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the identification and development of autophagy regulators for potential therapeutic applications in diseases such as cancer and neurodegenerative disorders by determining the up-regulation or down-regulation of Beclin 1 protein phosphorylation.
Implementation Method 1
an antibody specifically binding to Beclin 1 protein with the 30th amino acid residue serine phosphorylated
Data Source
AI summary
The present invention provides a method for screening for an autophagy activator or inhibitor comprising the steps of: (a) making a test material to be analyzed come into contact with cells containing Beclin 1 protein; and (b) analyzing the degree of phosphorylation at the 30th serine amino acid residue of the Beclin 1 protein. The test material is determined to be an autophagy activator when the phosphorylation of the Beclin 1 protein is up-regulated, and the test material is determined to be an autophagy inhibitor when the phosphorylation of the Beclin 1 protein is down-regulated. The present invention first establishes, by ULK1, the mechanism of phosphorylation at the 30th serine amino acid residue of Beclin 1.